Answers are grounded in this paper and cite their sources.
Antinuclear antibodies (ANA) are autoantibodies directed against cellular nuclear components and are commonly used as serological markers in the investigation of autoimmune diseases, although they may also occur in other pathological conditions. This study aimed to evaluate ANA reactivity in 25 dogs and 44 cats and explore its potential clinical significance. Selected hematological and biochemical parameters were also compared according to ANA classification. Overall, 40/69 animals were ANA-reactive (58.0%), including 24/44 cats (54.5%) and 16/25 dogs (64.0%), with reactive results occurring in animals with various clinical conditions and in some considered clinically healthy. No significant differences were identified between ANA-reactive and ANA-negative animals for the evaluated hematological parameters. Among biochemical parameters, an unadjusted difference in globulin concentration was observed in cats (p = 0.032), with slightly lower median values in ANA-reactive animals; no significant differences were identified in dogs. These preliminary findings indicate that ANA results should be interpreted in conjunction with clinical findings and complementary diagnostic investigations rather than as an isolated indicator of systemic autoimmune disease. Larger studies using species-validated methods are required.
No takes yet. Share an insight, caveat, or question.
Horhogea et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: